Unmatched Access, Unprecedented Opportunity
AnaBios offers early human insights into the drug development process and is redefining “First-in-Human” studies. Leveraging extensive knowledge of human tissue procurement and strategic utilization, AnaBios provides the unprecedented opportunity to de-risk drug development programs by assessing the safety and efficacy of drugs at the preclinical stage.
Predicting Safety and Toxicity in Humans
Predict toxicity risks and safety of preclinical molecules, as well as de-convolute clinical adverse effects.